Resistia jobs and careers

About Resistia

We bring over 15 years of experience in biofilm R&D to market, developing next-generation antimicrobials against resistant biofilm-related infections. We are at the front door of a global AMR silent pandemic. Where antibiotics fail, our solution begins. How BIG is the problem? Biofilms are the source of a significant medical unmet need: Responsible for +80% human chronic infections. Enables bacteria to be 1,000 times more resistant to antibiotics, causing treatment failure in 8 out of 10 cases. Emerging innovative treatment alternatives have still limited effectiveness and stability. 400B is the global annual spent in human biofilm-related infections.